| Bioactivity | Tauro-β-muricholic acid-d4-1 (T-βMCA-d4-1) sodiumis the deuterium labeledTauro-β-muricholic acid(HY-N9933)[1]. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| Name | Tauro-β-muricholic acid-d4-1 sodium |
| Formula | C26H40D4NNaO7S |
| Molar Mass | 541.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
Tauro-β-muricholic acid-d4-1 sodium
CAS: F: C26H40D4NNaO7S W: 541.71
Tauro-β-muricholic acid-d4-1 (T-βMCA-d4-1) sodiumis the deuterium labeledTauro-β-muricholic acid(HY-N9933).
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.